TC Biopharm
TC Biopharm is a clinical-stage biopharmaceutical company focused on the development of allogeneic gamma-delta T cell therapies for the treatment of cancer. The company utilizes its proprietary technology platform to engineer immune cells aimed at addressing unmet medical needs in oncology.
Brand Identity Data
HQ Country
United Kingdom
HQ City
Edinburgh
Founded
2013
EU Headquartered
No
EU Manufactured
Yes
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026